© 2021 MJH Life Sciences and Drug Topics. All rights reserved.
© 2021 MJH Life Sciences™ and Drug Topics. All rights reserved.
November 12, 2021
One year after the close of the Increasing Access to Contraception (IAC) Learning Community, participants had sustained their efforts in support of at least 1 goal: to improve adolescent girls' and women’s access to the full range of contraceptive options.
Although the authors say their findings shed light on possible disruptions to insulin supply during COVID-19, they note they could not adjust for those with diabetes who died.
November 10, 2021
The company plans to submit these results to the FDA and EMA for review.
November 09, 2021
Non-White patients were more likely to express beliefs that medications are both harmful and overused, leading to a decrease in medication adherence.
The FDA has approved Dyanavel XR, extended release once-daily tablets for the treatment of attention-deficit/hyperactivity disorder.
Patients with rheumatoid arthritis should be encouraged to receive their yearly flu vaccine.
November 08, 2021
Patients require more information on biosimilars, but the number of switches a patient experience does not negatively impact their satisfaction with care.
Pharmacists are a key part of the multidisciplinary approach that health care providers should take when tapering patients off opioid therapy.
Fewer patients today are likely to express an unwillingness to change their RA medications compared with patients 15 years ago, survey results showed.
November 07, 2021
A poster presentation at ACR Convergence 2021 compared risk factors for long-term opioid use among DMARD and non-DMARD users.